Loading insider details...
Beta
Latest Form 4 (Sep 18, 2026): Exercise/Conversion of 2,500 TVTX shares, $68.8K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 18, 2026 | Travere Therapeutics, Inc. (TVTX) | Exercise/Conversion | 2,500 | $68.8K |
| Apr 16, 2026 | Travere Therapeutics, Inc. (TVTX) | Exercise/Conversion | 2,500 | $56.0K |
| Feb 4, 2026 | Travere Therapeutics, Inc. (TVTX) | Grant/Award | 15,180 | n/a |
| Dec 30, 2025 | Travere Therapeutics, Inc. (TVTX) | Sale | 7,402 | $296.1K |
| Dec 16, 2025 | Travere Therapeutics, Inc. (TVTX) | Sale | 2,910 | $104.8K |
| Nov 6, 2025 | Travere Therapeutics, Inc. (TVTX) | Exercise/Conversion | 10,000 | $252.5K |
| Feb 13, 2025 | Travere Therapeutics, Inc. (TVTX) | Exercise/Conversion | 10,000 | $162.3K |
| Feb 5, 2025 | Travere Therapeutics, Inc. (TVTX) | Grant/Award | 13,000 | n/a |
| Jan 24, 2025 | Travere Therapeutics, Inc. (TVTX) | Sale | 925 | $17.5K |
| Dec 28, 2024 | Travere Therapeutics, Inc. (TVTX) | Exercise/Conversion | 15,000 | $190.1K |